A Nested Case-control Study on the Secondary Prevention of Ischemic Stroke and TIA by Hypertension Health Education Protocol (HHEP): The Post-Stroke Preventive Trial
|ClinicalTrials.gov Identifier: NCT01812421|
Recruitment Status : Unknown
Verified April 2013 by Guangzhou University of Traditional Chinese Medicine.
Recruitment status was: Recruiting
First Posted : March 18, 2013
Last Update Posted : April 4, 2013
Patients with a diagnosis of ischemic stroke or TIA (ISTIA), who are treated at hospital are asked to participate in our pre specified hypertension health education protocol (HHEP) after discharge from our hospital.HHEP was used as secondary prevention treatments of stroke and cardiovascular diseases.
HHEP consists of several items such as controlling the patient's hypertension level, monitoring the adherece of antihypertensive agents, reducing risk factors of hytertension like tobacco smoking, obesity, and motivating the patient to physical activity and to a healthy diet.
Patients will receive visits by a study nurse with the aim of supervising, monitoring, and recording the adherence of HHEP. The patients will be classified as different adherence level at the end of the study according to their adherence condition.
This study is aimed at testing the hypothesis that controlling hypertension and its risk factors was more effective than those do not receive HHEP in reducing the recurrence of stroke and cardiovascular diseases.
|Condition or disease||Intervention/treatment||Phase|
|To Investigate the Relationship Between the Adherence of HHEP After ISTIA and Stroke Recurrence or Cardiovascular Events.||Other: Hypertension Health Education Protocol (HHEP)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||500 participants|
|Masking:||None (Open Label)|
|Study Start Date :||April 2013|
|Estimated Primary Completion Date :||April 2015|
|Experimental: Ischemic Stroke or TIA (ISTIA) patients||Other: Hypertension Health Education Protocol (HHEP)|
- Nonfatal vascular events: ischemic or hemorrhagic stroke recurrence (ICD-9 431 or ICD-10 I61), or myocardial infarction(MI) (ICD-9 410 or ICD-10 I21). [ Time Frame: 1 year ]
- vascular death (death within 30 days after a vascular event) and all-cause mortality. [ Time Frame: 1 year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01812421
|Contact: YeFeng Cai, Dr.||email@example.com|
|Brain Center,Guangdong Province Hospital of Traditional Chinese Medicine||Recruiting|
|Guangzhou, Guangdong, China, 510120|
|Contact: YeFeng Cai, Dr. firstname.lastname@example.org|
|Sub-Investigator: ZiYi Zhou, Master|
|Sub-Investigator: Lin Wei, Master|
|Sub-Investigator: XiaoPei Zhang, Master|